Analyze Diet

Topic:Gonadotropin-Releasing Hormone

Gonadotropin-Releasing Hormone (GnRH) is a neuropeptide hormone produced in the hypothalamus of horses. It is involved in the regulation of reproductive processes by stimulating the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) from the anterior pituitary gland. These hormones are key regulators of gonadal function, influencing processes such as estrus, ovulation, and spermatogenesis. The study of GnRH in horses includes understanding its physiological roles, mechanisms of action, and its application in managing reproductive health. This page compiles peer-reviewed research studies and scholarly articles that explore the function, regulation, and clinical applications of Gonadotropin-Releasing Hormone in equine reproduction.
Role of prolactin in the gonadotroph responsiveness to gonadotrophin-releasing hormone during the equine annual reproductive cycle.
Journal of neuroendocrinology    March 2, 2010   Volume 22, Issue 6 509-517 doi: 10.1111/j.1365-2826.2010.01986.x
Hodson DJ, Townsend J, Gregory SJ, Walters C, Tortonese DJ.A combined suppressive effect of prolactin (PRL) and dopamine on the secretion of luteinising hormone (LH) at the level of the pituitary gland has been identified in sheep, a short-day breeder. However, little is known about the role of PRL in the intra-pituitary regulation of the gonadotrophic axis in long-day breeders. In the present study, we investigated the effects of PRL on LH and follicle-stimulating hormone (FSH) secretion during the equine annual reproductive cycle. Horse pituitaries were obtained during the breeding season (BS) and nonbreeding season (NBS). Cells were dispersed, plat...
Gonadotrophin subunit and GnRH receptor gene expression in the pars distalis of the equine pituitary.
General and comparative endocrinology    December 10, 2008   Volume 160, Issue 3 236-242 doi: 10.1016/j.ygcen.2008.11.029
Townsend J, Westcott K, Tortonese DJ.In the horse, pronounced changes in fertility occur annually in response to photoperiod. However, the mechanisms regulating gonadotrophin synthesis and release in this species remain unclear. Here, we investigated the expression of gonadotrophin subunits and GnRH receptor (GnRH-R) mRNA in the pituitary glands of Thoroughbred horses during the breeding (BS) and non-breeding (NBS) season. Seasonal effects on the prevalence of gonadotrophs in the pars distalis were also examined. GnRH-R and common alpha-, LHbeta- and FSHbeta-subunit mRNA contents were determined by Northern analysis and the preva...
Suppression of testicular function and sexual behavior by vaccination against GnRH (Equity) in the adult stallion.
Animal reproduction science    November 20, 2008   Volume 115, Issue 1-4 88-102 doi: 10.1016/j.anireprosci.2008.11.011
Janett F, Stump R, Burger D, Thun R.The aim of this study was to evaluate the effects of an anti-GnRH vaccine on testosterone concentration, antibody titer, scrotal width, semen quality and sexual behavior in the stallion. Adverse reactions to the vaccine were also determined. Eight clinically healthy sexually experienced stallions aged between 6 and 15 years from the National Stud in Avenches (Switzerland) were used. Five stallions were immunized 3 times at an interval of 4 and 8 weeks, respectively, with 200 microg of a GnRH-protein conjugate (Equity, CSL Limited, Australia) intramuscularly in the neck and 3 control animals re...
Effect of suppression of FSH with a GnRH antagonist (acyline) before and during follicle deviation in the mare.
Reproduction in domestic animals = Zuchthygiene    October 10, 2008   Volume 44, Issue 3 504-511 doi: 10.1111/j.1439-0531.2008.01222.x
Checura CM, Beg MA, Gastal EL, Gastal MO, Wiltbank MC, Parrish JJ, Ginther OJ.A GnRH antagonist (Acyline) was used to study the role of FSH in early development of a follicular wave in 61 mares. In Experiment 1, a single dose of 3 mg per mare, compared with 0 and 1 mg, suppressed both the FSH and follicle responses to exogenous GnRH. In Experiment 2, high concentrations of FSH were induced by two successive ablations of all follicles >/= 6 mm on days 10 and 13 (day 0 = ovulation). A single treatment with Acyline resulted in significantly greater suppression of plasma concentrations of FSH than a single treatment with charcoal-extracted follicular fluid (source of inh...
Kisspeptin immunoreactive neurons in the equine hypothalamus Interactions with GnRH neuronal system.
Journal of chemical neuroanatomy    August 7, 2008   Volume 36, Issue 3-4 131-137 doi: 10.1016/j.jchemneu.2008.07.008
Decourt C, Tillet Y, Caraty A, Franceschini I, Briant C.To determine if kisspeptin could be implicated in the control of reproduction in equine species, we studied the distribution of kisspeptin neurons and their anatomical interactions with GnRH neurons in the hypothalamus of pony mares. Brains were collected in three pony mares between 2 and 4h after ovulation. One major population of kisspeptin immunoreactive cell bodies was found in the arcuate nucleus (ARC), where they extended from the middle of the nucleus to the premammillary recess. Kisspeptin immunoreactive varicose fibers extended from the preoptic area to the mammillary nuclei, with imp...
Induction of estrus and ovulation: why some mares respond and others do not.
Theriogenology    June 12, 2008   Volume 70, Issue 3 445-447 doi: 10.1016/j.theriogenology.2008.04.040
Samper JC.The two most common procedures for breeding management of mares involve induction of luteolysis and induction of ovulation. Although both of these events are usually achieved, physiologic conditions affect the timing of the response. In a diestrus mare treated with prostaglandin F(2alpha) (PGF), or a PGF analogue, it is well documented that, on average, the interval from treatment to the onset of estrus is 3-4 days, whereas ovulation occurs 8-10 days after treatment. However, the diameter of the ovulatory follicle, as well as its status at the time of PGF treatment, determines the intervals fr...
Regulation of testicular function in the stallion: an intricate network of endocrine, paracrine and autocrine systems.
Animal reproduction science    May 9, 2008   Volume 107, Issue 3-4 179-196 doi: 10.1016/j.anireprosci.2008.05.004
Roser JF.It is well established in many mammalian species, including the horse that normal testicular function is dependent upon a functional hypothalamic-pituitary-testicular (HPT) axis, which involves classic feedback mechanisms. The major HPT hormones involved in the stallion are gonadotropin-releasing hormone (GnRH), luteinizing hormone (LH), follicle stimulating hormone (FSH), testosterone (T), estrogens (Es) and inhibin (INH). Although prolactin (PRL) fluctuates with season in the stallion and both PRL and thyroid hormone (TH) affect reproduction in other male species, their effects on stallion r...
Repeatability of preovulatory follicular diameter and uterine edema pattern in two consecutive cycles in the mare and how they are influenced by ovulation inductors.
Theriogenology    February 1, 2008   Volume 69, Issue 6 681-687 doi: 10.1016/j.theriogenology.2007.11.019
Cuervo-Arango J, Newcombe JR.Follicular diameter is used as a guiding tool to predict ovulation in the mare. However, the great range in preovulatory follicular diameter makes prediction of optimal breeding time based on follicular diameter unreliable. Uterine edema pattern is also useful to determine the best time to breed, since intensity of edema tends to dissipate as ovulation approaches, however, not every mare follows this pattern. The aims of this study were to assess the repeatability of preovulatory follicular diameter and uterine edema pattern in two consecutive spontaneous cycles and to determine how induction ...
A single subcutaneous administration of buserelin induces ovulation in the mare: field data.
Reproduction in domestic animals = Zuchthygiene    September 12, 2007   Volume 42, Issue 5 550-554 doi: 10.1111/j.1439-0531.2006.00822.x
Levy I, Duchamp G.The aim of the present study, was to evaluate whether a single subcutaneous administration of the GnRH analogue buserelin could induce ovulation in the mare during the breeding season. Two studies were carried out under field conditions. In Experiment 1, 90 cycles of trotter mares aged 2-7 years, were assigned to a buserelin group (Bus1) or to a control group (Control), in the presence of a >/=35 mm pre-ovulatory follicle, with uterine oedema and a relaxed cervix. Ten mares were assigned to the two groups for 32 cycles in Bus1 and 52 cycles in Control, two mares received only Bus1 for three...
Continuous administration of low-dose GnRH in mares II. Pituitary and ovarian responses to uninterrupted treatment beginning near the autumnal equinox and continuing throughout the anovulatory season.
Theriogenology    June 27, 2007   Volume 68, Issue 4 673-681 doi: 10.1016/j.theriogenology.2007.05.057
Collins SM, Zieba DA, Williams GL.We tested the hypothesis that continuous subcutaneous treatment with low-dose GnRH, administered to mares from late September/early October through March, would prevent the development of seasonal anovulation. Quarter Horse mares (n=20) were stratified by age and body condition score and assigned randomly to either a saline control (n=9) or a GnRH (n=11) treatment group. Gonadotropin-releasing hormone was delivered continuously via osmotic minipumps, with sham pumps placed in control mares. Initial pumps were inserted on Day 3 following ovulation or during the follicular phase if the next anti...
Continuous administration of low-dose GnRH in mares I. Control of persistent anovulation during the ovulatory season.
Theriogenology    May 7, 2007   Volume 68, Issue 1 67-75 doi: 10.1016/j.theriogenology.2007.03.024
Williams GL, Amstalden M, Blodgett GP, Ward JE, Unnerstall DA, Quirk KS.Three experiments were conducted during the operational breeding season to confirm that continuous, subcutaneous infusion of low-dose GnRH would not disrupt established estrous cycles (Experiment 1), and test the hypotheses that a similar treatment would stimulate secretion of LH and induce development of ovulatory follicles in persistently anovulatory mares (Experiments 2 and 3). Treatment with GnRH (5 microg/h) increased (P<0.001) serum P4 during the luteal phase (7.7+/-0.5 versus 6.4+/-0.5 ng/mL), tended to increase serum LH (2.6+/-0.27 versus 1.9+/-0.25 ng/mL), and did not modify intero...
Suppression of behavioural and physiological oestrus in the mare by vaccination against GnRH.
Australian veterinary journal    February 16, 2007   Volume 85, Issue 1-2 39-45 doi: 10.1111/j.1751-0813.2006.00092.x
Elhay M, Newbold A, Britton A, Turley P, Dowsett K, Walker J.To examine the immunogenicity of an equine immunocontraceptive vaccine and its efficacy in controlling hormone-related behaviour. Methods: A total of 24 mares at two sites in Australia were vaccinated with an immunocontraceptive vaccine comprising gonadotrophin releasing hormone (GnRH) conjugated to a carrier protein in immunostimulating complex as an adjuvant. Twelve animals at each site received a placebo of adjuvant alone and served as controls for seasonal oestrus, hormonal and behaviour patterns. Animals were observed for injection site reactions, ovarian and follicular activity, and seru...
Successful timing of ovulation using deslorelin (Ovuplant) is labour-saving in mares aimed for single ai with frozen semen.
Reproduction in domestic animals = Zuchthygiene    November 17, 2006   Volume 41, Issue 6 535-537 doi: 10.1111/j.1439-0531.2006.00709.x
Hemberg E, Lundeheim N, Einarsson S.To minimize the number of matings/inseminations, controlled ovulation has been practised since a long time ago. A potent short-term implant, releasing the GnRH analogue deslorelin (Ovuplant((R))) has been used in Australia and North America for several years for hastening the ovulation time in mares, but the product is not registered on the European market. This study was aimed to investigate: (1) ovulation time in mares implanted with Ovuplant when the largest follicle was 42 mm or more in size, (2) repeatability of ovulation time in successive oestruses when treated with Ovuplant, (3) pregna...
Evaluation of three equine FSH superovulation protocols in mares.
Animal reproduction science    October 5, 2006   Volume 102, Issue 1-2 48-55 doi: 10.1016/j.anireprosci.2006.09.027
Logan NL, McCue PM, Alonso MA, Squires EL.Superovulation could potentially increase embryo recovery for immediate transfer or cryopreservation. The objectives were to evaluate the effect of pretreatment with progesterone and estradiol (P+E) on follicular response to eFSH and compare doses of eFSH and ovulatory agents on follicular development and ovulation in mares. In Experiment 1, 40 mares were assigned to one of four treatment groups. Group 1 consisted of untreated controls. Group 2 mares were administered eFSH without pretreatment with P+E. Group 3 mares were administered P+E for 10 days starting in mid-diestrus followed by eFSH t...
Influence of immunization against GnRH on reproductive cyclicity and estrous behavior in the mare.
Theriogenology    June 15, 2006   Volume 66, Issue 8 1866-1875 doi: 10.1016/j.theriogenology.2006.04.038
Imboden I, Janett F, Burger D, Crowe MA, Hässig M, Thun R.The aim of this study was to evaluate the effect of active immunization against GnRH on ovarian activity, plasma progesterone and estradiol concentrations and on estrous behavior in adult mares. Eighteen cyclic mares were randomly divided into a treatment and control group. Nine mares were immunized twice with 2 mL (400 microg GnRH-protein conjugate) of a GnRH-vaccine (Improvac, CSL Limited, Australia) administered intramuscularly, 4 weeks apart. Control mares received the same amount of saline solution. Ovaries and uterus of all mares were examined weekly by ultrasonography from 3 weeks befor...
Superovulation in mares.
Animal reproduction science    June 12, 2006   Volume 99, Issue 1-2 1-8 doi: 10.1016/j.anireprosci.2006.04.054
Squires EL, McCue PM.Embryo recovery from single ovulating mares is approximately 50 per cent per estrous cycle. Superovulation could be used to increase embryo recovery and provide extra embryos for embryo freezing. This review addresses some historical approaches to superovulation, as well as examines factors that affect the response of mares to equine FSH. eCG, GnRH and inhibin vaccines have been of limited success in stimulating multiple ovulation. Numerous studies have shown that injection of equine pituitary extract (EPE) will result in three to four ovulations per estrous cycle and two embryos. A purified, ...
Gonadotropin secretion and pituitary responsiveness to GnRH in mares with granulosa-theca cell tumor.
Theriogenology    May 2, 2006   Volume 66, Issue 5 1210-1218 doi: 10.1016/j.theriogenology.2006.03.030
Zelli R, Sylla L, Monaci M, Stradaioli G, Sibley LE, Roser JF, Munro C, Liu IK.Granulosa-theca cell tumors (GTCTs) are able to secrete variable amounts of sex steroids and immunoreactive inhibin (ir-INH). Although the pituitary appears to be affected by the presence of a GTCT, pituitary responsiveness to exogenous GnRH has not been examined. The aims of the present study were to: (i) assess the plasma hormone concentrations of ir-INH, gonadotropins and sex steroids in eight mares with GTCT and (ii) assess the responsiveness of pituitary gonadotroph cells to exogenous GnRH stimulus both before and after tumor removal. In seven mares, the contralateral ovary was firm, smal...
Pregnancy rates, LH and progesterone concentrations in mares treated with a GnRH agonist.
Animal reproduction science    February 20, 2006   Volume 97, Issue 1-2 55-62 doi: 10.1016/j.anireprosci.2005.12.011
Kanitz W, Schneider F, Hoppen HO, Unger C, Nürnberg G, Becker F.The aim of the study was to investigate the effect of the GnRH agonist Buserelin given on day 10 after ovulation on pregnancy rate and concentrations of progesterone and LH. Altogether 191 warmblood mares were used for two trials. Fresh or frozen/thawed semen from 27 stallions was used for A.I. In trial A 171 mares received either Buserelin (Receptal, Hoechst, Germany, 40 microg/animal) or 10 ml 0.9% NaCl (placebo). On day 16 after A.I. pregnancy diagnosis was performed by ultrasound scanning of the uterus. For statistical analysis, data were analyzed by a mixed model, with four fixed factors ...
The pituitary and testicular responses to GnRH challenge between 4 and 14 months of age in thoroughbred colts born in spring and autumn.
Animal reproduction science    September 7, 2005   Volume 88, Issue 3-4 287-298 doi: 10.1016/j.anireprosci.2004.12.008
Brown-Douglas CG, Firth EC, Parkinson TJ, Fennessy PF.Gonadotropin releasing-hormone analogue (buserelin) challenges were carried out every 8 weeks from 4 to 14 months of age on thoroughbred colts born in the spring (n = 6) or autumn (n = 5) to define the onset of puberty. In all colts, luteinizing hormone (LH) secretion followed a seasonal pattern, with high baseline and maximal concentrations in the spring and summer and low concentrations in the winter. Testosterone concentrations were undetectable before spring and, thus, autumn-born colts were younger than spring-born colts when a testosterone response to buserelin was first observed. Mean w...
LH and IGF-1 release during oestrus and early luteal phase in lactating and non-lactating horse mares.
Animal reproduction science    April 14, 2005   Volume 91, Issue 1-2 97-106 doi: 10.1016/j.anireprosci.2005.03.002
Deichsel K, Aurich J, Parvizi N, Bruckmaier RM, Aurich C.The aim of the present study was to determine effects of lactation on basal LH and IGF-1 concentrations and on the LH response to a GnRH-analogue at different stages of the oestrous cycle in mares. A total of 17 cyclic Haflinger mares were included in the study. Experiments were performed on lactating mares in first postpartum oestrus, the subsequent early luteal phase, and second postpartum oestrus. Non-lactating mares were used in oestrus and early luteal phase. Blood samples were taken for 1 h at 15 min intervals. Mares were then injected with the GnRH-analogue buserelin (GnRHa; 5 microg i....
Effects of GnRH immunization in sexually mature pony stallions.
Animal reproduction science    March 16, 2005   Volume 86, Issue 3-4 247-259 doi: 10.1016/j.anireprosci.2004.07.010
Turkstra JA, van der Meer FJ, Knaap J, Rottier PJ, Teerds KJ, Colenbrander B, Meloen RH.Immunization against gonadotrophin releasing hormone (GnRH) was studied as an alternative for the commonly used surgical castration in stallions. Two GnRH vaccines comprising non-mineral oil adjuvants were evaluated for their potential to induce high antibody titers directed against GnRH and subsequent effects on reproductive characteristics. Twelve sexually mature male hemicastrated Shetland ponies were assigned to three groups. Group 1 and 2 were injected with 1mg peptide equivalent of G6k-GnRH-tandem-dimer conjugated to ovalbumin (OVA) in CoVaccine HT adjuvant (GnRH/CoVaccine) and in Carbop...
Clinical use of twice daily injections of buserelin acetate to induce ovulation in the mare.
Veterinary research communications    September 18, 2004   Volume 28 Suppl 1 169-172 doi: 10.1023/b:verc.0000045398.62134.e4
Camillo F, Pacini M, Panzani D, Vannozzi I, Rota A, Aria G.No abstract available
Suppressing reproductive activity in horses using GnRH vaccines, antagonists or agonists.
Animal reproduction science    July 24, 2004   Volume 82-83 633-643 doi: 10.1016/j.anireprosci.2004.04.009
Stout TA, Colenbrander B.There are a number of situations in which it is desirable to suppress part or all of the reproductive endocrine system in a horse, notably the competing animal whose tractability during training, or performance during competition, is compromised by the expression of sexual or aggressive behavior. The current therapeutic approaches to reproductive endocrine suppression include gonadectomy and progestagen administration, where the former carries surgical risks and entails irreversible loss of breeding potential, and effective progestagen therapy requires frequent administration for extended peri...
Effects of a new injectable short-term release deslorelin in foal-heat mares.
Theriogenology    July 15, 2004   Volume 62, Issue 5 831-836 doi: 10.1016/j.theriogenology.2003.12.004
Stich KL, Wendt KM, Blanchard TL, Brinsko SP.Mares treated with subcutaneous deslorelin implants on the first postpartum estrus early in the breeding season had significant reductions in the number of large follicles at early pregnancy examinations and delayed return to estrus (in mares that failed to become pregnant); these adverse effects were attributed to a prolonged release of the drug from the implant. In 2003, an injectable short-term release (<24 h) deslorelin product became available. The objective of this study was to determine if this product would hasten ovulation in early foaling first postpartum estrus mares without reducin...
Attempt to control the day of ovulation in cycling pony mares by associating a GnRH antagonist with hCG.
Domestic animal endocrinology    June 29, 2004   Volume 27, Issue 2 165-178 doi: 10.1016/j.domaniend.2004.03.004
Briant C, Ottogalli M, Guillaume D.With the objective of controlling the day of ovulation, 40 mares were assigned to a control or three treated groups: A3d, A4d, and A5d. The treated groups received antarelix (Teverelix 0.01 mg/kg, i.v., twice a day) for 3, 4, or 5 days from the day the dominant follicle (F1) reached 28 mm (=D0), and one injection of hCG (1600 IU, i.v.) on D1, D2, or D3, respectively. Control mares received one injection of hCG when F1 reached 35 mm. Plasma LH, FSH, progesterone, and total estrogens were assayed. In the A3d, A4d, and A5d groups, 9 (90%), 6 (60%), and 5 (50%) out of 10 mares, respectively, ovula...
Deslorelin on Day 8 or 12 postovulation does not luteinize follicles during an artificially maintained diestrous phase in the mare.
Theriogenology    May 26, 2004   Volume 62, Issue 1-2 57-64 doi: 10.1016/j.theriogenology.2003.07.024
Glazar BS, McCue PM, Bruemmer JE, Squires EL.Practical estrus synchronization schemes are needed for mares. The Ovsynch synchronization protocol for cattle involves the administration of gonadotropin-releasing hormone (GnRH) to induce ovulation or luteinization of dominant follicles during the luteal phase and prostaglandin 7 days later to cause regression of any luteal tissue and development of a preovulatory follicle. An Ovsynch-type synchronization program potentially could be developed for horses if luteinization or ovulation of diestrous follicles occurred in response to GnRH treatment. The objective of this study was to determine i...
LH and testosterone responses to five doses of a GnRH analogue (buserelin acetate) in 12-month-old Thoroughbred colts.
Theriogenology    March 24, 2004   Volume 61, Issue 6 1051-1060 doi: 10.1016/j.theriogenology.2003.05.003
Brown-Douglas CG, Firth EC, Parkinson TJ, Fennessy PF.To determine the responsiveness of the pituitary-gonadal axis of peri-pubertal colts to GnRH, buserelin (0.5, 1, 5, 10 and 40 microg) was given to 13 male Thoroughbred yearlings ( n=3-8 colts per dose). Jugular venous blood samples were taken at -10, 0, 10, 20, 30, 40, 60, 120 and 180 min relative to buserelin administration. Increases (P < 0.05) in LH concentrations occurred in colts that received 5, 10, or 40 microg buserelin, but not in those that received 0.5 or 1 microg. Peak LH concentrations and mean area under the curve were higher (P < 0.05) in colts receiving 40 microg busereli...
Influence of exogenous GnRH on sexual behavior and frozen/thawed semen viability in stallions during the non-breeding season.
Theriogenology    December 4, 2003   Volume 61, Issue 1 159-171 doi: 10.1016/s0093-691x(03)00205-x
Sieme H, Troedsson MH, Weinrich S, Klug E.Twelve fertile stallions were divided into two groups, either receiving gonadotropin-releasing hormone (GnRH) (n = 6) or Placebo (n = 6). Based on the history of frozen/thawed semen characteristics three stallions within each group were assigned as being "good freezers" [GnRH (+); Placebo (+)] and three stallions were assigned as being "poor freezers" [GnRH (-); Placebo (-)]. The study was performed as a "blinded" investigation and stallions were treated twice daily by an intramuscular injection of 1 ml GnRH (Buserelin), 50 microg) or Placebo. The experiment was divided into three time periods...
Effects of deslorelin acetate implants in horses: single implants in stallions and steroid-treated geldings and multiple implants in mares.
Journal of animal science    May 30, 2003   Volume 81, Issue 5 1300-1307 doi: 10.2527/2003.8151300x
Johnson CA, Thompson DL, Cartmill JA.Three experiments were performed to test the following hypotheses: 1) stallions and/or progesterone-estradiol-treated geldings could serve as models for the effects of a single implant of the GnRH analog, deslorelin acetate, on LH and FSH secretion by mares; and 2) multiple implants of deslorelin acetate could be used as a means of inducing ovarian atrophy in mares for future study of the mechanisms involved in the atrophy observed in some mares after a single implant. In Exp. 1, nine light horse stallions received either a single deslorelin implant (n = 5) or a sham injection (n = 4) on d 0. ...
Use of a GnRH antagonist, antarelix, associated or not with hCG, to control ovulation in cyclic pony mares.
Domestic animal endocrinology    May 14, 2003   Volume 24, Issue 4 305-322 doi: 10.1016/s0739-7240(03)00012-2
Briant C, Ottogalli M, Morel M, Guillaume D.The GnRH antagonist antarelix (Teverelix) was administered to mares (0.01 mg/kg, i.v., twice a day) during the periovulatory period. In Experiment 1, 20 mares were divided into a treated (A3d-) and a control (Control-) group. A3d- mares received antarelix for 3 days from the day when the dominant follicle (F1) reached 32 mm (D0). In Experiment 2, 10 mares were divided into a treated (A6d+) and a control (Control+) group. A6d+ mares received antarelix for 6 days from D0 and hCG was injected in all animals (1600 IU, i.v.) on D1. Pregnancies were determined 13 days after ovulation. In both experi...